Plaque Assay Calculators

0 calculators tagged with “Plaque Assay”

The plaque assay is the gold-standard method for quantifying infectious virus particles, producing a direct count of the number of plaque-forming units (PFU) in a virus stock. Developed in the 1950s by Renato Dulbecco, it remains the most accurate and widely used method for measuring viral titer in virology research, vaccine production, and antiviral drug testing. Each plaque visible in a cell monolayer represents the progeny of a single infectious virus particle — making the assay a direct, visual count of infectivity.

All Calculators

No calculators found for this topic.

What Is a Plaque Assay?

A plaque assay quantifies the number of infectious virus particles (virions) in a sample by allowing each particle to infect a cell in a monolayer, replicate, and spread to neighboring cells, creating a visible clear zone (plaque) of lysed or dead cells. By counting plaques at known dilutions, the titer of the original stock can be calculated.

Plaque Assay Protocol

  1. Prepare serial dilutions of the virus stock (typically 10-fold dilutions: 10⁻², 10⁻³, 10⁻⁴ etc.)
  2. Infect cell monolayers (6-well or 12-well plates) with each dilution for 1 hour (adsorption period), rocking occasionally
  3. Overlay the monolayer with semi-solid agarose or carboxymethylcellulose (CMC) medium to restrict virus diffusion and ensure localized plaques
  4. Incubate for the appropriate time (48 hours to several days depending on virus)
  5. Stain the monolayer (crystal violet, neutral red, or MTT) to visualize plaques
  6. Count plaques in wells with 20–100 plaques per well for accuracy

Calculating Viral Titer

Titer (PFU/mL) = Number of plaques / (Volume added in mL × Dilution factor)

Example: 45 plaques counted at 10⁻⁵ dilution, 0.1 mL added per well:
Titer = 45 / (0.1 × 10⁻⁵) = 45 / 10⁻⁶ = 4.5 × 10⁷ PFU/mL

Plaque Morphology

Plaques vary in size, clarity, and appearance depending on the virus and cell type. Large, clear plaques suggest rapid, complete cell lysis; small, turbid plaques suggest slower or incomplete lysis. Plaque morphology is used to distinguish virus strains, select for attenuated variants (used in vaccine development), and identify spontaneous mutants.

Limitations and Alternatives

  • Some viruses do not produce visible plaques (non-cytolytic viruses)
  • TCID₅₀ (tissue culture infective dose) is an alternative end-point dilution assay for non-plaque-forming viruses
  • Focus-forming assay: Uses immunostaining instead of cell lysis to detect infected foci for viruses that don't lyse cells
  • Fluorescent focus assay (FFA): Fluorescently labeled antibodies detect infected cells, enabling automation

Glossary

Plaque Assay
A virology technique that quantifies infectious virus particles by counting visible clear zones (plaques) in an infected cell monolayer. Each plaque originates from a single infectious virion. Results expressed as PFU/mL.
PFU (Plaque-Forming Unit)
The unit of viral infectivity measured by plaque assay — the number of virus particles capable of forming a visible plaque. Used to express viral titer as PFU/mL.
TCID₅₀
The dilution of a virus preparation that infects 50% of inoculated cell cultures. Used for viruses that don't form plaques. Approximately equivalent to 0.7 PFU by statistical conversion, though this varies.

Frequently Asked Questions

PFU/mL stands for plaque-forming units per milliliter — the number of infectious virus particles per mL of stock that are capable of forming a visible plaque in a cell monolayer. Each PFU represents one infectious virion that successfully infected a cell, replicated, and produced enough progeny to create a visible zone of dead cells. PFU/mL is the most accurate measure of infectious viral titer.

Titer (PFU/mL) = Number of plaques / (Volume inoculated in mL × Dilution factor). For example, 35 plaques counted at 10⁻⁴ dilution with 0.1 mL inoculated: Titer = 35 / (0.1 × 10⁻⁴) = 35 / 10⁻⁵ = 3.5 × 10⁶ PFU/mL. Always count wells containing 20–100 plaques for the most accurate titer estimate.

A semi-solid overlay (agarose, methylcellulose, or CMC) is added after virus adsorption to restrict virus diffusion in the medium. Without the overlay, newly produced virions would diffuse freely and create a uniform infection across the monolayer rather than discrete localized plaques. The overlay confines each viral infection to neighboring cells, producing countable, well-separated plaques.

PFU (plaque-forming units) directly counts infectious particles from visible plaques in a cell monolayer — each plaque = one original infectious particle. TCID₅₀ (50% tissue culture infective dose) is the dilution that infects 50% of inoculated cell cultures — it's a statistical estimate, not a direct count. TCID₅₀ is used for viruses that don't form plaques. The conversion is approximate: 1 PFU ≈ 0.7 TCID₅₀, but this varies by virus and assay.